Matthias Schellenberg, born on September 21, 1964, began his career in 1994 as a graduate in business administration at the University of Cologne, working at the advisory firm KPMG in Frankfurt and New York. Subsequently, he held leadership positions in investment banking and asset management at Commerz Financial Products, Dresdner Kleinwort Wasserstein, Zurich Capital Markets and PioneerInvestments. From 2006, Schellenberg established the German branch of ING Investment Management before leading its business development in Europe and Latin America from The Hague between 2008 and 2012. Between 2013 and 2016, as a member of the board of directors of UBS Deutschland AG, he was responsible for asset management and compliance. Subsequently, he served as CEO of Merck Finck Privatbankiers AG from 2017 to 2020 and concurrently served as a member of the Global Management Team of KBL – European Private Bankers. Matthias Schellenberg has been CEO of apoBank since 1 March 2022.
